Interpretation of Epithelial Lining Fluid Concentrations of Antibiotics against Methicillin Resistant Staphylococcus aureus.
- Author:
Sungmin KIEM
1
;
Jerome J SCHENTAG
Author Information
- Publication Type:Review
- Keywords: Epithelial lining fluid; Methicillin-resistant Staphylococcus aureus; Bronchoalveolar lavage; Protein binding
- MeSH: Anti-Bacterial Agents*; Bronchoalveolar Lavage; Diffusion; Linezolid; Lung; Methicillin Resistance*; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Protein Binding; Staphylococcus aureus*; Teicoplanin; Vancomycin
- From:Infection and Chemotherapy 2014;46(4):219-225
- CountryRepublic of Korea
- Language:English
- Abstract: Although antibiotics whose epithelial lining fluid (ELF) concentrations are reported high tend to be preferred in treatment of pneumonia, measurement of ELF concentrations of antibiotics could be misled by contamination from lysis of ELF cells and technical errors of bronchoalveolar lavage (BAL). In this review, ELF concentrations of anti-methicillin resistant Staphylococcus aureus (MRSA) antibiotics were interpreted considering above confounding factors. An equation used to explain antibiotic diffusion into CSF (cerebrospinal fluid) was adopted: ELF/free serum concentration ratio = 0.96 + 0.091 x ln (partition coefficient / molecular weight1/2). Seven anti-MRSA antibiotics with reported ELF concentrations were fitted to this equation to see if their ELF concentrations were explainable by the penetration capacity only. Then, outliers were modeled under the assumption of varying contamination from lysed ELF cells (test range 0-10% of ELF volume). ELF concentrations of oritavancin, telavancin, tigecycline, and vancomycin were well described by the diffusion equation, with or without additional impact from cell lysis. For modestly high ELF/free serum concentration ratio of linezolid, technical errors of BAL should be excluded. Although teicoplanin and iclaprim showed high ELF/free serum ratios also, their protein binding levels need to be cleared for proper interpretation. At the moment, it appears very premature to use ELF concentrations of anti-MRSA antibiotics as a relevant guide for treatment of lung infections by MRSA.
